21050 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof Protease inhibitors
Sub-classes:TARGETING AND LYSING MICROTHROMBI ASSOCIATED WITH ABERRANT BLOOD CLOTTING
#2ACELLULAR PLACENTAL PREPARATIONS
#3Methods and Compositions for Treating Diabetes
#4SYSTEMS AND METHODS FOR GENETIC MODULATION TO TREAT LIVER DISEASE
#5METHODS FOR TREATMENT OF DISEASES
#6METHODS AND COMPOSITIONS FOR INHIBITING ADAM9 BIOLOGICAL ACTIVITIES
#7CONJUGATED C1 ESTERASE INHIBITOR AND USES THEREOF
#8SERPIN PEPTIDES AND METHODS OF USING THE SAME
#9DEVICE, SYSTEM AND METHODS FOR THE ORAL DELIVERY OF THERAPEUTIC COMPOUNDS
#10COMPOSITIONS AND METHODS FOR TREATING ALLERGIC INFLAMMATORY CONDITIONS
#11COMPOSITIONS AND METHODS FOR ENHANCING CARDIOMYOCYTE TRANSPLANT ENGRAFTMENT
#12ALPHA-1 ANTITRYPSIN PRODUCED FROM YEAST FOR USE IN THE TREATMENT OF VIRAL INFECTIONS
#13TREATMENT OF HEREDITARY ANGIOEDEMA WITH AAV GENE THERAPY VECTORS AND THERAPEUTIC FORMULATIONS
#14DPP-4 INHIBITOR AND PRODUCTION METHOD THEREFOR
#15FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS
#16ORAL ALGAL OIL BASED GASTRO-INTESTINAL TRACT PERMEABLE PEPTIDE COMPOSITION
#17KLK5 INHIBITORY PEPTIDE
#18PROTEASE INHIBITORS
#19Methods and Compositions for Treating Diabetes
#20COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS
#21ALPHA-1-ANTITRYPSIN (AAT) IN THE TREATMENT AND/OR PREVENTION OF NEUROLOGICAL DISORDERS
#22TREATING RESPIRATORY INFECTIONS
#23TREATMENT OF HYPOPARATHYROIDISM
#24Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof
#25METHODS AND COMPOSITIONS FOR INCREASING PROTEIN EXPRESSION IN GENETICALLY ENGINEERED BACTERIA
#26PROTEASE INHIBITORS FOR TREATMENT OF CORONAVIRUS INFECTIONS
#27Use Of Naturally Occurring Cyclic Peptides For Treatment Of SARS-COV-2 Infection
#28DPEP-1 Binding Compositions and Methods of Use
#29Treatment of Glaucoma by Neuroprotection
#30Device, system and methods for the oral delivery of therapeutic compounds
#31INHIBITORS FOR USE IN TREATING LIVER DISORDERS
#32Skin Probiotics
#33Compositions Containing a Pharmacophore with Selectivity to Diseased Tissue and Methods of Making Same
#34METHODS AND MATERIALS FOR TREATING GASTROINTESTINAL DISORDERS
#35TREATMENT OF RETINAL DISORDERS
#36COMPOSITIONS FOR ALTERING A MICROGLIAL CELL, AND METHODS OF USE THEREFORE
#37USE OF ELAFIN FOR DISORDERS ASSOCIATED WITH ELASTASE INDEPENDENT INCREASE IN TROPONIN
#38Composition comprising highly-concentrated Alpha1 proteinase inhibitor and method for obtaining thereof
#39Compositions and Methods for Treating Granulomatosis with Polyangiitis
#40CYSTEINE PROTEASE INHIBITORS FOR USE IN THE PREVENTION AND/OR TREATMENT OF CORONAVIRUS
#41METHODS AND COMPOSITIONS FOR TREATING DIABETES
#42METHODS AND COMPOSITIONS USING SERPIN PRODUCING BACTERIA
#43Methods for treating pulmonary disease using inter-alpha inhibitor proteins
#44METHOD OF USING SUBSTRATES OF AKR1Bl/AKR1B10 AS ANTI-CANCER DRUGS
#45COMPOSITION COMPRISING PEPSTATIN AND ALGINIC ACID OR A SALT THEREOF, AND USE THEREOF
#46EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF
#47METHOD FOR PRODUCING ENHANCED ANTI-INFLAMMATORY / ANTI-CATABOLIC AGENTS FROM AUTOLOGOUS PHYSIOLOGICAL FLUID
#48EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF
#49NEUROPROTECTIVE PEPTIDE
#50Compositions and methods for treating allergic inflammatory conditions
#51Protease inhibitors for treatment of coronavirus infections
#52Therapy for the Treatment of Cancer
#53ACELLULAR PLACENTAL THERAPIES FOR NECROTIZING ENTEROCOLITIS
#54TREATMENT OF MEDICAL CONDITIONS BY STEM CELL TRANSPLANTS AND STEM CELL ACTIVATION
#55Ocular delivery of cell permeant therapeutics for the treatment of retinal edema
#56KLK5 inhibitory peptide
#57TARGETING CAPN9/CAPNS2 ACTIVITY AS A THERAPEUTIC STRATEGY FOR THE TREATMENT OF MYOFIBROBLAST DIFFERENTIATION AND ASSOCIATED PATHOLOGIES
#58OXIDATION-RESISTANT SERPINS
#59METHODS OF IMPROVING ORGAN FUNCTION
#60COMPOSITIONS AND METHODS FOR REACTIVATING LATENT IMMUNODEFICIENCY VIRUS AND/OR TREATING IMMUNODEFICIENCY VIRUS INFECTION
#61METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#62USE OF ELAFIN FOR DISORDERS ASSOCIATED WITH ELASTASE INDEPENDENT INCREASE IN TROPONIN
#63USE OF ELAFIN FOR DISORDERS ASSOCIATED WITH ELASTASE INDEPENDENT INCREASE IN TROPONIN
#64METHODS AND COMPOSITIONS FOR TREATING AGING-ASSOCIATED CONDITIONS
#65Composition comprising highly-concentrated α1 proteinase inhibitor and method for obtaining thereof
#66Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof
#67METHODS FOR TREATMENT OF DISEASES
#68ADDITIVE FOR MEDIUM FOR PROMOTING PRODUCTION OF PARACRINE FACTOR
#69KLK5 inhibitory peptide
#70Targeted epigenetic therapy against distal regulatory element of TGFβ2 expression
#71INHIBITION OF SPONTANEOUS METASTASIS VIA PROTEIN INHIBITORS OF CYSTEINE PROTEASES
#72VECTOR PRODUCTION IN SERUM FREE MEDIA
#73Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders
#74COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER WITH LEKTI
#75COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF SKIN DISEASES AND DISORDERS WITH LEKTI
#76Combined administration of cysteine-aspartic protease inhibitors with P2Y12 receptor antagonists protects the heart against myocardial infarction
#77Methods and compositions for treating diabetes
#78Methods of reducing neuroinflammation or toxicity induced by amyloid beta (abeta) using glucocorticoid induced leucine zipper (GILZ) analog peptides
#79COMPOSITIONS AND METHODS FOR PLATELET ENRICHED FIBRIN CONSTRUCTS
#80Enhancing radiation sensitivity comprising administering PMVK inhibiting siRNA and shRNA
#81Circular strained zymogen compositions and methods of use
#82Pharmaceutical formulations of C1 esterase inhibitor
#83USE OF INHIBITORS OF IL-36 PROTEOLYTIC PROCESSING FOR THE TREATMENT AND/OR REDUCTION OF INFLAMMATION
#84METHODS OF TREATING ANTIBODY-MEDIATED REJECTION IN ORGAN TRANSPLANT PATIENTS WITH C1-ESTERASE INHIBITOR
#85Peptide inhibitors of insulin-degrading enzyme
#86Compositions and methods for treating allergic inflammatory conditions
#87Compositions and methods for treatment of protease mediated disease
#88Methods for the regulation of matrix metalloproteinase expression
#89Device, system and methods for the oral delivery of therapeutic compounds
#90Composition for ameliorating loss of hair and graying of hair, and use thereof
#91Methods and compositions for treating aging-associated conditions
#92Acellular placental preparations
#93Compounds and methods for treatment and prevention of Flavivirus infection
#94TREATMENT OF HUMAN METAPNEUMOVIRUS
#95Intranasal Delivery of Cell Permeant Therapeutics
#96THERAPEUTIC COMPOSITION CONTAINING ANTITHROMBIN GAMMA
#97Formulations for oral administration of active agents
#98Therapy using a factor XII inhibitor in a neurotraumatic disorder
#99DPEP-1 binding compositions and methods of use
#100Composition comprising highly-concentrated ALPHA1 proteinase inhibitor and method for obtaining thereof
#101Methods and compositions for inhibiting ADAM 9 biological activities
#102Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#103Methods and Compositions for Treating Diabetes
#104Methods for treatment of diseases
#105Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders
#106USE OF ELAFIN FOR DISORDERS ASSOCIATED WITH ELASTASE INDEPENDENT INCREASE IN TROPONIN
#107Compositions comprising PEDF-derived short peptides and uses thereof
#108Prevention and reduction of blood loss
#109Egg protein formulations and methods of manufacture thereof
#110Combinatory treatment strategies of cancer based on RNA polymerase I inhibition
#111Tripeptides having angiotensin converting enzyme inhibitory activity and uses thereof
#112Implantable matrix having optimum ligand concentrations
#113Methods and kits for assessing Heparanase procoagulant activity, compositions comprising Heparanase, and methods for the treatment of coagulation-related disorders
#114Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof
#115OCULAR DELIVERY OF CELL PERMEANT THERAPEUTICS FOR THE TREATMENT OF RETINAL EDEMA
#116Fusion proteins for treating inflammatory diseases
#117INHIBITION OF SPONTANEOUS METASTASIS VIA PROTEIN INHIBITORS OF CYSTEINE PROTEASES
#118METHODS AND MATERIALS FOR MODULATING DEUBIQUITINASES AND UBIQUITINATED POLYPEPTIDES
#119Method of using substrates of AKR1B1/AKR1B10 as anti-cancer drugs
#120Compositions containing a pharmacophore with selectivity to diseased tissue and methods of making same
#121Methods for the regulation of matrix metalloproteinase expression
#122Compositions and methods for treating allergic inflammatory conditions
#123VARIANTS OF AMYLOID beta-PROTEIN PRECURSOR INHIBITOR DOMAIN
#124TREATMENT OF DISEASE WITH LACTIC ACID BACTERIA HAVING STABLY INTEGRATED TRAPPIN-2
#125Methods and compositions for treating aging-associated conditions
#126Conjugated C1 Esterase Inhibitor and Uses Thereof
#127Composition for ameliorating loss of hair and graying of hair, and use thereof
#128Serpin reactive center loop peptides and methods of use
#129Targeting CAPN9/CAPNS2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies
#130Dual-site BACE1 inhibitors
#131D-amino acid compounds for liver disease
#132Pharmaceutical composition for treatment of or remission in elderly or terminal cancer patient
#133BACE1 inhibitor peptides
#134METHODS OF TREATING ANTIBODY-MEDIATED REJECTION IN ORGAN TRANSPLANT PATIENTS WITH C1-ESTERASE INHIBITOR
#135TREATMENT OF HYPOPARATHYROIDISM
#136PHARMACEUTICAL FORMULATIONS OF C1 ESTERASE INHIBITOR
#137FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS WITH CONTROLLED ABSORPTION PROFILE
#138Spatiotemporal Delivery Vehicle and Related Methods
#139STABILIZATION ADRENOMEDULLIN DERIVATIVES AND USE THEREOF
#140Formulations for oral administration of active agents
#141COMPOUNDS AND METHODS FOR TREATMENT AND PREVENTION OF FLAVIVIRUS INFECTION
#142NOVEL DIAGNOSTIC AND THERAPEUTIC TARGET IN INFLAMMATORY AND/OR CARDIOVASCULAR DISEASES
#143Device, system and methods for the oral delivery of therapeutic compounds
#144COMPOSITIONS, METHODS AND USES FOR ALPHA-1 ANTITRYPSIN OR DERIVATIVES THEREOF
#145Methods and Compositions for Preserving the Viability of Photoreceptor Cells
#146Method for modifying T cell population
#147Compositions and methods for CaMKII inhibitors and uses thereof
#148Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
#149Conjugated C1 Esterase Inhibitor and Uses Thereof
#150Modulation and detection of a neuronal alternative splicing regulatory network for treatment and diagnosis of neurological disorders
#151Compositions and methods for cell transplantation
#152USE OF CASPASE-2 INHIBITORS TO TREAT AND PREVENT THE METABOLIC SYNDROME
#153Method for treatment of inflammatory skin disorders with inhibitors of IL-36 proteolytic processing
#154Compounds for enzyme inhibition
#155DPEP-1 binding compositions and methods of use
#156Functional Peptide Analogs of PEDF
#157Pigment epithelium-derived factor (PEDF) and peptide derivatives thereof for use in osteoblast differentiation and bone growth
#158Macrocyclic inhibitors of flaviviridae viruses
#159THERAPY USING A FACTOR XII INHIBITOR IN A NEUROTRAUMATIC DISORDER
#160Compositions and methods for cell transplantation
#161Prevention and reduction of blood loss
#162Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation related disorders
#163Compositions and method for treatment of inflammatory bowel disease
#164Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#165In vivo individualized systemic immunotherapeutic method and device
#166Compositions and methods for treating granulomatosis with polyangiitis
#167Cardiovascular disease treatment and prevention
#168Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
#169Methods for the regulation of matrix metalloproteinase expression
#170Methods and materials for treating cancers that express reduced levels of wild-type p53 polypeptides
#171Method for producing a mixture of neutral oligosaccharides extracted from flaxseed
#172Method for treatment of GM1 gangliosidosis
#173Polyplexes
#174Egg protein formulations and methods of manufacture thereof
#175Compositions and methods for CaMKII inhibitors and uses thereof
#176Serpins: methods of therapeutic β-cell regeneration and function
#177METHODS AND COMPOSITIONS FOR TREATING NAFLD, HEPATIC STEATOSIS, AND SEQUELAE THEREOF
#178Human Notch Receptor Mutations and Their Use
#179Macrocyclic inhibitors of flaviviridae viruses
#180Pharmaceutical compositions containing polypeptides derived from α-1 antitrypsin and methods of use thereof
#181Methods of treating antibody-mediated rejection in organ transplant patients with C1-esterase inhibitor
#182Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders
#183Functional peptide analogs of PEDF
#184Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
#185Compositions and methods for the treatment of retinal degeneration
#186Macrocyclic compounds for suppressing replication of hepatitis C virus
#187Method of treatment and agents useful for same
#188Methods and compositions for treating diabetes
#189Dosage form comprising lopinavir and ritonavir
#190Factor XII inhibitors for the treatment of neurological inflammatory disorders
#191Prevention and reduction of blood loss
#192Rapid infusion of autologous bone marrow derived stem cells
#193Peptide YY analogs
#194Hepatitis C virus inhibitors
#195Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
#196Rapid infusion of autologous bone marrow derived stem cells
#197Rapid infusion of autologous bone marrow derived stem cells
#198Treatments for
#199Methods and compositions for reducing amyloid beta levels
#200Combination therapy using immunoglobulin and C1-Inhibitor
#201Device, system and methods for the oral delivery of therapeutic compounds
#202Compositions of lopinavir and ritonavir
#203Use of matrix metalloproteinase inhibitors to treat tuberculosis
#204Methods of regulating glucose metabolism, and reagents related thereto
#205Macrocyclic broad spectrum antibiotics
#206Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation related disorders
#207Method for ameliorating radiation exposure effects with alpha-1 antitrypsin
#208GLUE COMPOSITION FOR LUNG VOLUME REDUCTION
#209Compounds for enzyme inhibition
#210Compounds for enzyme inhibition
#211Compounds for enzyme inhibition
#212Macrocyclic inhibitors of flaviviridae viruses
#213CRYSTAL STRUCTURE AND PEPTIDE INHIBITORS OF HAUSP DEUBIQUITINASE
#214Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis
#215COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION
#216Biomarker and uses thereof in diagnosis, treatment of autism
#217Pharmaceutical combinations comprising a thionucleotide analog
#218Formulation for the prevention of cardiovascular disease
#219Cysteine protease inhibitors
#220NOVEL DIAGNOSTIC AND THERAPEUTIC TARGET IN INFLAMMATORY AND/OR CARDIOVASCULAR DISEASES
#221Factor XII inhibitors for treating interstitial lung disease
#222Compositions and methods for platelet enriched fibrin constructs
#223METHODS AND INTRAVASCULAR TREATMENT DEVICES FOR TREATMENT OF ATHEROSCLEROSIS
#224Method for treating amyloid disease
#225Use of PEDF-derived polypeptides for treating liver cirrhosis
#226METHODS AND COMPOSITIONS FOR MODULATING HEPSIN ACTIVATION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR
#227MODULATION OF PLASMA MEMBRANE HUMAN LEUKOCYTE ELASTASE
#228Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
#229COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NECROSIS
#2302′allene-substituted nucleoside derivatives
#231Macrocyclic inhibitors of hepatitis C virus replication
#232Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides
#233Method of regulating glucose metabolism, and reagents related thereto
#234PREVENTION OF THROMBUS FORMATION AND/OR STABILIZATION
#235Glue composition for lung volume reduction
#236Hepatitis C virus inhibitors
#237TARGETS FOR TREATMENT OF CHLAMYDIAL INFECTIONS
#238ANTI-INFECTIVE COMPOUNDS AND USES THEREOF
#239Method of regulating glucose metabolism, and reagents related thereto
#240Methods and Compositions for Preserving the Viability of Photoreceptor Cells
#241Method for prophylaxis or treatment of feline infectious peritonitis
#242Method of inhibiting platelet aggregation and clot formation
#243Prevention and reduction of blood loss
#244USE OF FURIN CONVERTASE INHIBITORS IN THE TREATMENT OF FIBROSIS AND SCARRING
#245READY-TO-USE BIVALIRUDIN COMPOSITIONS
#246SHUTTER DEVICE FOR CAMERA
#247Process of inhibiting cell death in injured cartilage
#248Hepatitis C virus inhibitors
#249Treatment of an intestinal adenoma and/or adenocarcinoma by inhibition of notch pathway activation
#250Cathepsin L mediated diseases and associated methods and products
#251USE OF PROTEASE INHIBITORS AND GRF MOLECULES IN COMBINATION THERAPY
#252USE OF INSULIN FOR THE TREATMENT OF CARTILAGINOUS DISORDERS
#253Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same
#254Nematode-extracted serine protease inhibitors and anticoagulant proteins
#255Linked diimidazole antivirals
#256Dynamin mediated diseases and associated methods and products
#257METHODS OF TREATING ALZHEIMER'S DISEASE
#258Therapeutic hybrid implantable devices
#259METHODS AND REAGENTS FOR SCREENING NEW DRUGS AND FOR TREATING ION PUMP ASSOCIATED DISORDERS AND DISEASES
#260Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors
#261Methods, Compositions and Device for Directed and Controlled Heating and Release of Agents
#262METHODS AND COMPOSITIONS FOR MODULATING HEPSIN ACTIVATION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR
#263Methods and compositions for reducing amyloid beta levels
#264Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
#265METHODS AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND DISORDERS
#266METHOD OF TREATING ACUTE ST-ELEVATION MYOCARDIAL INFARCTION WITH A DELTA PKC ANTAGONIST
#267DRUG THERAPY FOR CELIAC SPRUE
#268Caspase-8 and inflammation, infection and wound healing
#269Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
#270Kallikrein Inhibitors and Anti-thrombolytic Agents and Uses Thereof
#271Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#272Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#273Oligopeptides as coating material for medical products
#274Elastase inhibitor and acute leukemia
#275Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#276Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#277Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#278Method for treating transplant rejection
#279COMPOUNDS FOR FLAVIVIRIDAE TREATMENT
#280Compounds for enzyme inhibition
#281Process of inhibiting cell death in injured cartilage
#282Method for treating amyloid disease
#283NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#284Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication
#285Glue composition for lung volume reduction
#286Method of regulating glucose metabolism, and reagents related thereto
#287Prevention and reduction of blood loss
#288HIV Transcription Repressor Complex and Compositions and Methods Based Thereon
#289System comprising elastase
#290PREVENTION AND REDUCTION OF BLOOD LOSS
#291Prevention of thrombus formation and/or stabilization with inhibitors of factor XII or activated factor XII
#292Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#293Anti-Thrombotic Agents
#294Novel Indications for Transforming Growth Factor-Beta Regulators
#295Prevention and reduction of blood loss
#296Detection and Use of Prolylcarboxypeptidase
#297Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#298PREVENTION AND REDUCTION OF BLOOD LOSS
#299Prevention and Reduction of Blood Loss
#300Preventive or therapeutic agents for diseases including interleukin-18 inhibitor as an active ingredient